Cullinan Oncology Inc.

NASDAQ: CGEM · Real-Time Price · USD
7.83
0.02 (0.26%)
At close: May 27, 2025, 3:59 PM
7.82
-0.19%
After-hours: May 27, 2025, 04:04 PM EDT
0.26%
Bid 7.27
Market Cap 462.38M
Revenue (ttm) n/a
Net Income (ttm) -178.74M
EPS (ttm) -2.77
PE Ratio (ttm) -2.83
Forward PE -2.58
Analyst Buy
Ask 8.15
Volume 181,534
Avg. Volume (20D) 466,840
Open 7.88
Previous Close 7.81
Day's Range 7.80 - 8.00
52-Week Range 6.85 - 24.99
Beta -0.07

About CGEM

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CGEM
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for CGEM stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
3 months ago
+7.66%
Cullinan Therapeutics shares are trading higher af... Unlock content with Pro Subscription
7 months ago
+8.44%
Cullinan Therapeutics shares are trading higher after the FDA cleared the company's IND application for CLN-978.